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Cell migration and invasion require the coordinated
regulation of cytoskeletal architectural changes by
signaling factors, including the actin-binding protein
cortactin. Bacterial and viral pathogens subvert
these signaling factors to promote their uptake,
spread and dissemination. We show that the gastric
pathogen Helicobacter pylori (Hp) targets cortactin
by two independent processes leading to its tyrosine
dephosphorylation and serine phosphorylation to
regulate cell scattering and elongation. The phos-
phorylation status of cortactin dictates its subcellular
localization and signaling partners. Upon infection,
cortactin was found to interact with and stimulate
the kinase activity of focal adhesion kinase (FAK).
This interaction required the SH3 domain and phos-
phorylation of cortactin at serine 405 and a proline-
rich sequence in FAK. UsingHp as amodel, this study
unravels a previously unrecognized FAK activation
pathway. We propose that Hp targets cortactin to
protect the gastric epithelium from excessive cell lift-
ing and ensure sustained infection in the stomach.
INTRODUCTION
Eukaryotic cell motility and migration are crucial processes for
awide range of fundamental cellular activities and disease devel-
opment, including wound healing, vascular disease, osteopo-
rosis, mental retardation, chronic inflammatory disease, and
tumor cell invasion and metastasis (Yamaguchi and Condeelis,
2007; Weaver, 2008). The complex processes of cell migration
and invasion require dynamic regulation of the cortical actin
cytoskeleton, utilizing a network of signaling factors that
coordinate regulated changes in the cytoskeletal architecture.
Consequently, many bacterial and viral pathogens have adapted
specific mechanisms during evolution to subvert the host
cytoskeletal machinery to promote their uptake, spread, and520 Cell Host & Microbe 9, 520–531, June 16, 2011 ª2011 Elsevier Indissemination (Frischknecht and Way, 2001; Selbach and Back-
ert, 2005). The important gastric pathogen and type I carcinogen
Helicobacter pylori (Hp) targets multiple host cell signaling path-
ways, which are implicated in inflammation, proliferation, cell
scattering, migration, and elongation to both enhance bacterial
colonization and promote disease development (Polk and
Peek, 2010). Virulent Hp strains use a sophisticated type IV
secretion system to inject the cytotoxin-associated gene A
(CagA) effector protein into the cytoplasm of gastric epithelial
cells followed by tyrosine phosphorylation by Src and Abl
kinases to trigger global rearrangements in the host cell cyto-
skeleton, leading to cell scattering and elongation (Selbach
and Backert, 2005; Bourzac et al., 2007). Injected CagA can
profoundly induce theMEK kinase pathway, but the downstream
targets of activated ERK kinases during infection are fully
unknown (Mimuro et al., 2002; Brandt et al., 2005). In addition,
CagA interacts with several cellular proteins in a phosphoryla-
tion-dependent manner, including C-terminal Src kinase (Csk),
which inhibits the catalytic activity of Src by a negative feedback
loopmechanism (Tsutsumi et al., 2003). CagA-induced Src inac-
tivation leads to tyrosine dephosphorylation of Src substrates,
most notably cortactin (Selbach et al., 2003). However, the role
of tyrosine dephosphorylated cortactin in downstream signaling
is unknown.
Cortactin is now regarded as an integrator of signaling to the
actin cytoskeleton which is consistent with its domain structure
and identified binding partners. Cortactin is a multidomain
protein that was first identified as a substrate of Src kinase.
Subsequently, cortactin has been described as key regulator
of the actin cytoskeleton with roles in many actin-based cellular
processes, including cell migration and invasion (Yamaguchi
and Condeelis, 2007) and tumor cell metastasis (Li et al.,
2001). Cortactin possesses an N-terminal acidic domain (NTA)
that harbors a DDWmotif activating the Arp2/3 actin polymeriza-
tion machinery (Uruno et al., 2001; Weaver, 2008). The NTA
domain is followed by a series of repeat domains that bind
filamentous actin (F-actin). The C terminus contains a Src
homology 3 (SH3) domain that interacts with proline-rich binding
sequences in several cortactin interaction partners. These
include WIP, N-WASP, MLCK, dynamin-2, and others. Several
excellent reviews have highlighted the latter interactions andc.
Figure 1. Role of Cortactin in the Formation
of the Hp-Induced Elongation Phenotype of
AGS Cells
AGS cells were transfected with cortactin siRNA or
with a control siRNA and then infected with the Hp
strain P1 for 6 hr.
(A) Cortactin expressionwas examined bywestern
blot analysis. The a-GAPDH blot served as loading
control.
(B) Quantification of cortactin expression and
number of elongated AGS cells. Error bars
represent ± standard deviation (SD).
(C) Phase-contrast microscopy shows that the
Hp-induced phenotype is downregulated by cor-
tactin siRNA.
See also Figure S1.
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cancer progression, invasive growth and metastasis, and endo-
cytosis (Daly, 2004; Cosen-Binker and Kapus, 2006; Orth and
McNiven, 2006; Weaver, 2008; Ammer and Weed, 2008).
When analyzed by SDS-PAGE, cortactin migrates as an 80/
85 kDa doublet, and the size shift from p80 to p85 can be
induced by EGF treatment, but the exact mechanism is still not
clear (Campbell et al., 1999). Cortactin can be phosphorylated
by tyrosine kinases (Src, Fer, Syk, and Abl) and serine/threonine
kinases (ERK and PAK1) (Lua and Low, 2005). Src kinase targets
tyrosine residues Y-421, Y-466, and Y-482, while ERK phos-
phorylates serines S-405 and S-418 (Campbell et al., 1999),
which lie in a proline-rich area. In addition, PAK1 phosphorylates
S-113 (Webb et al., 2006). Interestingly, in vitro studies have
shown that phosphorylation-mimetic cortactin (S405/418D)
binds N-WASP at the SH3 domain, triggering Arp2/3-dependent
actin nucleation independent of the NTA domain (Martinez-
Quiles et al., 2004). The interaction of cortactin with N-WASP
in vivo promotes the localization of N-WASP to sites of actin
polymerization within invadopodia/podosomes (Mizutani et al.,
2002) and enhances cell movement (Kowalski et al., 2005).
Collectively, these studies suggest cortactin and N-WASP are
intimately intertwined in regulating Arp2/3 activity responsible
for cortical actin assembly.
Given the central position of cortactin in host signaling, it is
not surprising that many microbial pathogens target cortactin
functions for their own benefit during infections, suggestingCell Host & Microbe 9, 520–5that cortactin is an Achilles’ heel of the
actin cytoskeleton (Selbach and Back-
ert, 2005). Studies on the molecular
basis of the infections afflicted by patho-
gens like pathogenic Escherichia coli
(EPEC and EHEC), Shigella, Listeria,
Staphylococcus, and Hp have yielded
some further insights into the molecular
mechanisms of cortactin functions.
Intriguingly, invasion of host cells by
several pathogens stimulates tyrosine
phosphorylation of cortactin while Hp
induces tyrosine dephosphorylation (Sel-
bach and Backert, 2005). Thus, the aim
of the present study was to investigatein detail the role of cortactin serine phosphorylation during
infection.
RESULTS
Importance of Cortactin and Activation Status
of Kinases during Infection with Hp
After having established that Hp targets cortactin, the present
study was designed to investigate the molecular mechanism
of cortactin signaling during infection. First, we aimed to confirm
the importance of cortactin for phenotypic outcome. For this
purpose, AGS gastric epithelial cells were transfected with
cortactin small interfering RNA (siRNA) or a scrambled siRNA
control followed by infection with Hp wild-type (WT) for 6 hr
(Figure 1A). While nontransfected or siRNA control cells ex-
hibited the characteristic Hp-induced scattering and elongation
phenotype as reported earlier (Bourzac et al., 2007), siRNA-
based downregulation of cortactin expression by about
90% significantly inhibited the phenotype (Figures 1B and 1C).
These results suggest that cortactin is indeed involved in estab-
lishing the cell scattering and elongation phenotype during
infection.
Human cortactin possesses several known phosphorylation
sites and becomes phosphorylated on serine residues S-113,
S-405, and S-418 as well as on tyrosine residues Y-421, Y-470,
and Y-486 (corresponding to Y-421, Y-466, and Y-482 in mouse
cortactin) by PAK1, ERK1/2, and Src kinases (Figure S1A31, June 16, 2011 ª2011 Elsevier Inc. 521
Figure 2. Cortactin Becomes Phosphorylated on Serine Residues
S-113, S-405, and S-418 during Hp Infection
(A) Schematic presentation of the 80 kDa cortactin molecule. The serine
phosphorylation sites are highlighted on the left.
(B) AGS cells were infected for 6 hr with HpWT or DcagAmutant. Infected and
control cells were separated into membrane and cytoplasmic fractions. The
a-cortactin and a-integrin-b1 blots served as loading controls.
(C) Cortactin phosphorylation at the known serine residues S-113, S-405, and
S-418 was analyzed with the indicated phosphoserine-specific antibodies.
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522 Cell Host & Microbe 9, 520–531, June 16, 2011 ª2011 Elsevier Inavailable online). To investigate the role of cortactin phosphoryla-
tion, we first monitored the activities of each of these cortactin
kinases using activation-specific phospho-antibodies during
a time course of Hp infection between 0.5 and 8 hr. The results
show that the activity of both serine/threonine kinases PAK1
and ERK1/2 increases continuously during infection, whereas
c-Src is only transiently activated (0.5–2 hr) and then becomes in-
activated (Figures S1B and S1C). The activation of PAK1 and
ERK1/2, as well as the inactivation of c-Src, strictly correlated
with the Hp-induced elongation phenotype between 4 and 8 hr
(Figure S1D). These observations lead to the hypothesis that
infection may induce phosphorylation of cortactin at serine but
not tyrosine residues.
Subcellular Localization of Phospho-Cortactin during
Infection with Hp
The serine phosphorylation status of cortactin in cellular
processes including infection with microbes such as Hp is
completely unknown (Figure 2A). To examine this important
question, we generated phospho-specific a-cortactin anti-
bodies against the known serine residues S-113, S-405, and
S-418. After demonstrating their specificity (Figure S2A), we
next aimed to investigate the serine phosphorylation of endog-
enous cortactin p80/p85 proteins and its subcellular localiza-
tion during infection. For this purpose, AGS cells were infected
with Hp WT and an isogenic DcagA mutant, followed by a
biochemical fractionation into membrane and cytoplasmic frac-
tions. As a loading control, staining with a a-cortactin antibody
showed similar signals in all fractions, and a-integrin-b1 blots
revealed only signals in the membrane fraction but not in the
cytosol as expected (Figure 2B). Probing with the a-cortactin
phospho-antibodies showed almost no signal in noninfected
cells. After infection with WT Hp, strong bands for cortactin
phosphorylated at S-113, S-405, and S-418 appear and
these cortactin species are exclusively present in the
membrane fraction (Figure 2C). Similar results were obtained
with the DcagA mutant (Figure 2C). Interestingly, while the
a-cortactin-PS-113 stained both p80 and p85 to similar extent
during infection, the a-cortactin-PS-405 antibody exclusively
reacted with p85, and the a-Cortactin-PS-418 antibody with
p80. This result suggests that Hp induces cortactin phosphor-
ylation at S-113, S-405, and S-418 in a CagA-independent
manner. In agreement with downregulation of Src activity as
shown above and in our previous studies (Selbach et al.,
2003; Tegtmeyer et al., 2009), cortactin underwent tyrosine-
dephosphorylation upon infection with Hp WT in a fashion
dependent on CagA (Figure 2D). In addition, immunoprecipi-
tated phosphoserine cortactin did not react with any of the
phosphotyrosine-specific cortactin antibodies (Figure S2C).
Thus, infection with Hp specifically produces two cortactin
populations in gastric epithelial cells: (1) p80 (phosphorylated
at S-113 and S-418) and (2) p85 (phosphorylated at S-113
and S-405) (Figure S2D).Densitometric quantification of band intensities is also shown. Error bars
represent ± SD.
(D) Cortactin tyrosine phosphorylation was analyzed using an a-pan-
phosphotyrosine antibody.
See also Figure S2.
c.
Figure 3. Cortactin Forms a Complex with
FAK but Not with N-WASP or Actin during
Hp Infection
(A) AGS cells were infected for 6 hr with Hp WT
or DcagA mutant, followed by an IP with an
a-cortactin antibody. The blot was stripped and
reprobed with the indicated antibodies for N-
WASP and actin.
(C) Immunofluorescence analysis of noninfected
or infected AGS cells (6 hr). Cells were fixed and
costained with a-cortactin (red) and a-FAK (green)
antibodies. In noninfected cells, cortactin is mainly
located in the cytoplasm (arrowheads), while
FAK is located in focal adhesion contacts. In
Hp-infected cells, cortactin also colocalizes with
FAK at the tips of the elongated cells (arrows).
Quantification of the signals show that about 5%
of total cortactin and 3% of total FAK colocalize in
infected cells.
(D) AGS cells were transfected with indicated
GFP-cortactin constructs (48 hr). Cells were then
infected with Hp WT for 6 hr or left untreated, fol-
lowed by an IPwith an a-GFP antibody. The a-FAK
blot shows that FAK is in complex with cortactin
during Hp infection. This complex is not detect-
able with the GFP-cortactinDSH3 mutant or in
non-infected cells.
(B and E) Quantitation of band intensities was
performed with the Lumi-Imager F1. Error bars
represent ± SD.
See also Figure S3.
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during Hp Infection
To investigate the functional importance of cortactin domains
and individual phosphorylation sites during infection, we gener-
ated a series of GFP-cortactin mutants, including N- and
C-terminal deletions, W22A (deficient for Arp2/3 binding in
the NTA domain) as well as phosphorylation-deficient point
mutations (S/A, Y/F) and phosphorylation-mimetic mutants
(S/D, Y/D) (Figure S2E). Transfected AGS cells were infected
with Hp for 6 hr, and similar expression of all constructs was
confirmed (Figure S2A, Figure 4B, and data not shown). As
shown in Figure S2E, the Hp-induced elongation phenotype
is significantly increased by overexpressing WT cortactin,
suggesting a positive regulatory function in cell elongation.
The expression of cortactin containing W22A, S113A, or
S405/418A mutations resulted in an inhibitory effect, while
expression of single phosphomimetic S113D, S405D, andCell Host & Microbe 9, 520–5S418D mutants significantly increased
the phenotype. These findings lead us
to conclude that phosphorylation of cor-
tactin at S-113, S-405, and S-418 exhibit
supportive effects on the phenotype.
Interestingly, the S405/418D double or
S113/405/418D triple mutants did not
show this effect whereas the DSH3,
Y421/466/482D, or Y421D mutants
largely inhibited the phenotype (Fig-
ure S2E). This suggests that cortactin’s
serine phosphorylation sites and theSH3 domain are involved in signal transduction supporting the
phenotypic outcome, while tyrosine phosphorylation had
suppressive effects.
Hp Terminates the Interaction of Cortactin
with N-WASP and F-Actin
Next, we wanted to identify interaction partners of cortactin
and downstream signaling during Hp infection. We originally
proposed that serine-phosphorylated cortactin may bind
N-WASP, which then recruites and activates the Arp2/3 complex
to induce actin polymerization. To test this hypothesis, AGS cells
were infected for 6 hr with HpWT or DcagAmutant, followed by
immunoprecipitation (IP) with an a-cortactin antibody. Surpris-
ingly, N-WASP and actin were found in IPs with cortactin of
noninfected control cells, but this interaction was terminated
during infection with both strains (Figures 3A and 3B). These
results suggest that infections with Hp induce the dissociation31, June 16, 2011 ª2011 Elsevier Inc. 523
Figure 4. Cortactin Interacts with FAK
In Vitro, and Phosphorylation of Cortactin
at S-405 or S-418 Is Essential for the Binding
of FAK in Cells
(A) In vitro phosphorylation of GST-cortactin with
ERK, followed by incubation with FAK and GST
pulldown.
(B) AGS cells were cotransfected for 48 hr with
indicated GFP-cortactin constructs and HA-FAK
WT, followed by IP with an a-HA antibody. The IPs
were probed with a-HA to ensure equal amounts
of HA-FAK input.Western blot analysis with a-GFP
demonstrates that GFP-cortactin S405D and
S418D bind to HA-FAK WT.
(C) Band intensities were quantified with the Lumi-
Imager F1. Error bars represent ± SD.
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manner, and also release actin from the complex.
Identification of Focal AdhesionKinase as an Interaction
Partner of Cortactin
The above results led us propose that cortactin might interact
with as yet unidentified proteins during infection with Hp. To
address this question, we investigated the cellular localization
of cortactin before and after infection by immunofluorecence
microscopy. To this end, infected and noninfected AGS cells
were fixed and stained with the a-cortactin phosphoserine
antibodies, but unfortunately they were not useful for this
approach. Thus, we next stained cells with a specificmonoclonal
a-cortactin antibody. In noninfected cells, cortactin was
predominantly detected in a spot-like pattern in the cytosol
and in the membrane (Figure 3C, arrowheads). In contrast, in
cells infected with WT Hp, cortactin localized at the tip and at
the base of the characteristic cellular elongations (Figure 3C,
left panel, arrows). Interestingly, at these spots cortactin is
strongly colocalized with focal adhesion kinase (FAK), a well-
known protein marker of cellular focal adhesion contacts
(Figure 3C, right panel, arrows).
Based on the above findings, we proposed that a proportion
of cortactin molecules may interact directly with FAK upon
infection with Hp. To examine this hypothesis, we infected
AGS cells transfected with different GFP-cortactin constructs
with Hp or left them untreated, followed by IP using an a-GFP
antibody. The IPs were probed with a-GFP and a-FAK anti-
bodies, showing that FAK is in complex with cortactin and
that this interaction requires the presence of both Hp and the
SH3 domain in cortactin (Figures 3D and 3E). Since such an
interaction is yet not reported in the literature, our findings
were verified by reverse transfection experiments. For this
purpose, AGS cells were transfected with HA-tagged FAK524 Cell Host & Microbe 9, 520–531, June 16, 2011 ª2011 Elsevier Inc.followed by IP with an a-HA antibody,
showing that endogenous cortactin can
bind FAK in the presence of Hp but not
in uninfected cells expressing similar
amounts of HA-FAK (Figure S3A). Next,
we aimed to investigate whether both
purified proteins can interact in vitro.
For this purpose, GST-cortactin wasphosphorylated in vitro with ERK kinase followed by incubation
with recombinant FAK and GST pulldown. The results showed
that GST-cortactin phosphorylated by ERK at S-405 or S-418
can directly interact with FAK in the absence of other proteins
in vitro (Figure 4A).
Role of Cortactin Phosphorylation for the Interaction
with FAK
Remarkably, the protein complex of FAK with cortactin in cells
is only detectable after infection with Hp. This might be due to
the defined phosphorylation status of cortactin at S-405 and
S-418 as stimulated during Hp infection. To examine whether
this is the case, we transfected AGS cells with a series of
phosphorylation-deficient or phosphorylation-mimetic GFP-
cortactin constructs in the presence of WT HA-FAK. In this
experiment, the transfected cells were directly subjected to IP
with a-HA antibodies without prior Hp infection in order to
avoid further posttranslational modification of cortactin as
probably induced by the bacteria. The results show a very
weak signal for bound WT (unmodified) GFP-cortactin, as ex-
pected (Figures 4B and 4C). The strongest signals for bound
GFP-cortactin were detected for the phosphoserine-mimetic
mutant S405D followed by S418D, whereas very weak signals
were observed for the S405/418D double mutant or the
phosphotyrosine-deficient Y421/466/482F mutant (Figures 4B
and 4C). In contrast, no bound GFP-cortactin was detectable
for the phosphoserine-deficient mutant S405/418A and the
phosphotyrosine-mimetic mutant Y421/466/482D (Figures 4B
and 4C). These findings indicate that phosphorylation of cor-
tactin at individual S-405 and S-418 residues (but not on both
serines simultaneously) positively regulates the interaction of
cortactin with FAK, whereas phosphorylation of cortactin at
the tyrosine residues Y-421, Y-466, and Y-482 suppresses
this interaction.
Figure 5. Binding of Cortactin Requires a Proline-rich Region in FAK
and Is Associated with Increased FAK Kinase Activity
(A) Schematic presentation of the domain structure of FAK and its proline-rich
regions, PR1 and PR2 (gray). Two other PxxP motifs were discovered and
named PR3 and PR4 (black). The indicated prolines were substituted by
alanines.
(B) AGS cells were transfected with the indicated HA-FAK constructs. After
48 hr, cells were infected withHpWT for 6 hr followed by an a-HA IP. The input
amount of the HA-FAK constructs is shown. The a-cortactin blot shows that
the DPR3 mutant barely binds cortactin, suggesting that PR3 region is
important for the interaction with cortactin.
(C) The activity of FAK kinase was analyzed using the a-phospho-FAK (Y-397)
antibody. The results show that HA-FAKDPR1 and HA-FAKDPR2 are highly
activated during infection, while weak kinase activity was detectable with the
other FAK constructs.
(D) Densitometric measurement of band intensities revealed the percentage of
FAK activity and the relative amount of bound cortactin per input amount of
HA-FAK. Error bars represent ± SD.
See also Figure S4.
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Cell HInteraction of Cortactin with FAK Is Independent of Two
Characterized PxxP Motifs
In order to gain further evidence for the interaction of cortactin
with FAK, we next investigated the molecular interaction site in
FAK. Our favored hypothesis was that the SH3 domain of cortac-
tin, which is essential for recruitment to FAK, may bind to one of
two known SH3-binding sites or so-called PxxP motifs (Sieg
et al., 2000). These two PxxP motifs are located in the proline-
rich domains of FAK (PR1 and PR2, Figure S3B). To test whether
PR1 and PR2 are involved in cortactin binding, we transfected
AGS cells with HA-FAK WT, HA-FAKDPR1, or HA-FAKDPR1/
DPR2 constructs. After 48 hr, transfected cells were infected
with Hp for 6 hr, followed by an IP of FAK with a-HA-antibodies.
The a-HA control blot shows that equal amounts of HA-FAK are
present (Figures S3C and S3D). The blot was then incubatedwith
the a-cortactin antibody to detect bound endogenous cortactin.
Surprisingly, we detected strong signals for each of the WT or
mutant FAK constructs. To ensure the correctness of this result,
we repeated the experiment in transfected FAK-deficient fibro-
blasts (FAK/ cells) and performed the IP with a-cortactin anti-
bodies. The resulting western blots with a-cortactin and a-HA
antibodies revealed significant binding of the FAKDPR1 and
FAKDPR1/DPR2 mutants to endogenous cortactin in five inde-
pendent experiments (Figures S3E and S3F). In some of these
experiments, we even detected slightly higher amounts of
cortactin bound to FAKDPR1 and FAKDPR1/DPR2 mutants as
compared to WT FAK (data not shown). These findings led us
to conclude that neither PR1 nor PR2 of FAK is involved in direct
binding to cortactin.
FAK Binds to Cortactin by a PxxP Motif
Since the SH3 domain of cortactin is essential for the binding
to FAK and SH3 domain interactions are usually achieved via
PxxP sequence motifs, we next analyzed the FAK amino acid
sequence for other possible PxxP motifs. Interestingly, the
sequence analysis resulted in the identification of two PxxP
motifs located closely to PR1 and PR2 that we called PR3 and
PR4, respectively (Figure 5A). To investigate whether PR3 and/
or PR4 are involved in binding of cortactin, both proline residues
in each of these two motifs were replaced by alanines. The re-
sulting constructs were designated as HA-FAKDPR1/DPR3
and HA-FAKDPR1/DPR4 mutants (Figure 5A). AGS cells were
then transfected with each of these constructs for 48 hr and
subsequently infected with Hp for 6 hr, followed by an IP of
FAK with a-HA antibodies. The a-HA blot shows that similar
amounts of HA-FAK were precipitated from AGS cells (Fig-
ure 5B). Afterward, the blot was incubated with the a-cortactin
antibody to quantify amounts of bound cortactin. The resulting
densitometric analysis of the bands indicates again the strongest
signals for bound cortactin with the FAKDPR1 mutant and with
the FAKDPR1/DPR4 double mutant but not with the FAKDPR1/
DPR3 double mutant (Figures 5B and 5D). These observations
demonstrate that the PR3 region of FAK, but not the PR4 region,
is involved in binding of the SH3 domain of cortactin.
Binding of Cortactin Is Associated with Increased FAK
Kinase Activity
The results described above suggest that Hp induces cortactin
serine phosphorylation to mediate binding of FAK, possibly toost & Microbe 9, 520–531, June 16, 2011 ª2011 Elsevier Inc. 525
Figure 6. Importance of FAK Activation and
Complex Formation with Cortactin during
Hp Infection
(A) AGS cells were infected for 6 hr with HpWT or
DcagA mutant, followed by an a-cortactin IP. The
IPs were probed with the indicated antibodies.
(B) AGS cells were infected with Hp WT in the
presence/absence of 10 mM FAK inhibitor PF-
573228. The a-FAK blot confirms equal amounts
of protein in each lane. FAK activity was examined
by using a-phospho-FAK (Y-397) antibody.
(C) Quantitation of elongation phenotype and
percentage of FAK activity as reavealed by
densitometric measurement of band intensities.
Error bars represent ± SD.
(D) Microscopic analysis shows that treatment of
cells with PF-573228 blocked the elongation
phenoytpe.
See also Figure S5.
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aimed to investigate the activation status of FAK in the complex
with cortactin described above. For this purpose, the IPs
produced in Figure 5Bwere probedwith an antibody recognizing
autophosphorylated FAK on tyrosine residue Y-397, which is
indicative of FAK kinase activity (Hauck et al., 2002). As shown
in the respective phospho-blot (Figure 5C) and densitometric
analysis of the bands (Figure 5D), the strongest signals for
activated FAK were obtained for the FAKDPR1 and FAKDPR2
mutants. In contrast, a moderate FAK activity was observed
for the FAKDPR1/DPR2 double mutant and FAK WT, whereas
only a low kinase activity was observed for the FAKDPR1/
DPR3 and FAKDPR1/DPR4 double mutants in the presence of
Hp, similar to FAK WT in the noninfected control (Figures 5C
and 5D). Interestingly, the detected FAK activity for the
constructs correlates with their capacity to bind cortactin,
except for the FAKDPR1/DPR4 double mutant showing strong
binding to cortactin, but only a very low FAK kinase activity.
These findings indicate that binding of cortactin to FAK may
stimulate FAK kinase activity. To further support these observa-
tions, we tested whether cortactin can stimulate FAK in the
in vitro assay described above. Indeed, serine-phosphorylated
but not nonphosphorylated GST-cortactin can induce FAK526 Cell Host & Microbe 9, 520–531, June 16, 2011 ª2011 Elsevier Inc.activity on a variety of tyrosine sites as
monitored with phospho-specific anti-
bodies for Y-397, Y-407, and Y-576
(Figure S4A).
Role of Cortactin-FAK Interaction
during Infection with Hp
So far, we had demonstrated the binding
of FAK to cortactin by transfection
studies of tagged proteins. Thus, a further
important question was whether endog-
enous FAK and cortactin interact with
each other during Hp infection and
whether the bacterial protein CagA plays
a role in this scenario. For this purpose,
AGS cells were infected for 6 hr withWT Hp, or isogenic DcagA mutant, followed by an IP with
a-cortactin antibodies. The precipitates were then analyzed by
western blotting with several antibodies. The a-FAK blot re-
vealed that endogenous cortactin binds strongly to endogenous
FAK after Hp WT infection. Quantification of IPs and superna-
tants showed that about 5%–10% of total cortactin and about
4%–9% of total FAK are found in complex with each other,
whereas this binding is significantly blocked in infections with
DcagA mutants (Figure 6A). We then determined the activity
of FAK bound to cortactin using the phospho-antibodies for
Y-397, Y-407, and Y-576 as described above. The results
indicate that FAK activity is strongly elevated in the FAK-
cortactin complex produced during infection with WT but not
mutant Hp (Figure 6A). These results clearly demonstrate that
(1) the endogenous FAK and cortactin proteins interact with
each other during Hp infection, (2) this interaction correlates
with an increased FAK activity, and (3) this activity is lost upon
infection with the DcagA mutant. Finally, to prove whether
FAK kinase activity is equally important for phenotypic outcome
as the presence of cortactin, we pharmacologically inhibited
FAK kinase using PF-573228. This treatment significantly
blocked both FAK activity and Hp-induced elongation pheno-
type (Figure 6B–D).
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FAK Activation
The results described above suggest that cortactin binds FAK
both in vitro and during infection and that it may stimulate its
tyrosine kinase activity. Next, we investigated whether cortactin
expression is required for Hp-induced FAK activation in AGS
cells. For this purpose, cortactin expression was downregulated
with cortactin siRNA and scrambled siRNA control followed
by infection with Hp for 6 hr. siRNA-based downregulation of
cortactin expression by about 85% significantly inhibited the
activation of FAK by Hp as compared to the siRNA control
(Figures S4B and S4C). These results suggest that cortactin
plays a significant role in Hp-induced FAK activation, which is
in agreement with previous studies reporting that Hp profoundly
activates FAK during infection (Kwok et al., 2007; Tabassam
et al., 2008; Tegtmeyer et al., 2010), while transfected CagA in
complex with Shp-2 phosphatase alone has suppressive effects
in the absence of Hp (Tsutsumi et al., 2006), which can be ex-
plained by 76% less CagA-bound Shp-2 during infection
(Figures S4D–S4F).
Integrin-Mediated Cell Attachment Induces Serine
Phosphorylation of Cortactin and FAK Activation
The above observations suggest that Hpmay highjack cortactin
in a general host signaling pathway affecting cell adhesion. A
well-studied host model system is integrin-mediated cell adhe-
sion (Hauck et al., 2002). To investigate whether serine-phos-
phorylation of cortactin is also induced during cell attachment
to a given substratum, we prepared AGS cells for cell spreading
assays on immobilized fibronectin and polylysine as control. The
results show that most AGS cells adhere and spread on fibro-
nectin after 3 hr and this is associated with cortactin serine phos-
phorylation at S-405 and S-418 (but very little at S-113) and FAK
activation, while cells incubated on polylysine did not induce
these phosphorylation events nor cell spreading (Figure S5A).
Thus, integrin-mediated cell adhesion to the extracellular matrix
triggers increased serine phosphorylation of cortactin.
Phosphorylation of Cortactin on S-405 but Not S-418
Triggers FAK Activation
Finally, we aimed to investigate whether cortactin serine-phos-
phorylation per se, besides playing a role in binding to FAK,
may stimulate FAK’s tyrosine kinase activity in cells. To exclude
side effects produced by endogeneous cortactin, we transfected
cortactin-deficient knockout fibroblasts (Lai et al., 2009) with WT
GFP-cortactin or the corresponding S405D, S418D, and DSH3
mutants, respectively, in the absence of Hp. Equal amounts of
GFP-cortactin variants and lack of endogenous cortactin was
verified in the a-cortactin blot (Figures S5B and S5C). The same
samples were probed with the a-FAK-PY-397 antibody, which
shows that cortactin S405D but notWT, S418D, orDSH3 cortac-
tin mutants induced pronounced FAK phosphorylation. These
results confirm that S-405 plays an important role not only in
binding to FAK but also in activating its tyrosine kinase activity.
DISCUSSION
Cortactin is implicated inmultiple actin-based cellular processes
including the coordination of membrane dynamics and theCell Hreorganisation of the actin cytoskeleton. In these processes
cortactin functions as an adaptor protein and interacts with
components of diverse signal transduction pathways. It also
possesses activity to promote binding of the Arp2/3 complex
to produce actin filaments. Therefore, cortactin plays a key
role in a wide array of cellular functions, ranging from cell motility
and metastasis to endocytosis, and is also a common target
exploited by microbes during infection (Cosen-Binker and
Kapus, 2006; Selbach and Backert, 2005). However, the molec-
ular regulation of cortactin is widely unknown. In particular, the
role of cortactin serine phosphorylation for the function of its
SH3 domain to bind signaling factors in vivo is completely
unclear. Here, we report that the gastric pathogenHp specifically
induces the suppression of tyrosine-phosphorylated cortactin
and the enrichment of serine-phosphorylated cortactin to trigger
signaling involved in cell scattering and elongation. This pheno-
type requires the activation of FAK through the specific interac-
tion with cortactin phosphorylated at S-405 as summarized
in Figure 7. This study therefore identifies and characterizes a
previously unrecognized binding partner of cortactin and a
pathway for activating FAK.
Downegulation of Cortactin’s Tyrosine Phosphorylation
by Hp
Cortactin is a target for phosphorylation by Src tyrosine kinase
and by serine/threonine kinases, including ERK1/2 and PAK1.
Interestingly, while some pathogens induce tyrosine phosphory-
lation of cortactin, Hp suppresses its tyrosine phosphorylation
(Selbach and Backert, 2005). The latter is in agreement with
the present data showing that Src is only transiently activated
in infected AGS cells (0.5–2 hr) and then becomes inactive. Src
inactivation requires injected and phosphorylated CagA, which
then binds to and activates Csk, a well-known inhibitor of Src
(Tsutsumi et al., 2003). Src therefore plays two separate roles
in CagA-induced host cell signaling. First, c-Src is the kinase
of CagA and activates this molecule by phosphorylation.
Second, phospho-CagA induces defined phosphorylation and
dephosphorylation events within the c-Src molecule which
lead to the inactivation of c-Src (Selbach et al., 2003). Interest-
ingly, expression of constitutive-active Src inhibited cortactin
tyrosine dephosphorylation and cell elongation (Selbach et al.,
2003). In agreement with these findings, we found that expres-
sion of tyrosine phosphorylation-mimicking cortactin constructs
suppressed the phenotype similarly. Thus, Hp infection specifi-
cally accumulates the tyrosine-dephosphorylated form of cor-
tactin necessary for phenotypic outcome.
Induction of Cortactin’s Serine Phosphorylation by Hp
In contrast to Src, Hp activates PAK1 and ERK1/2 constitutively
over the entire course of infection. Since these are the kinases
of cortactin’s serine phosphorylation, we then generated phos-
pho-cortactin antibodies against all three known serine phos-
phorylation sites (S-113, S-405, and S-418). These antibodies
were proven to be highly specific for the corresponding phos-
pho-cortactin forms, which were indeed accumulated during
infection. Interestingly, CagA is not required for this process,
suggesting that the CagA-independent activation of the EGF
receptor/Ras/Raf/MEK/ERK pathway by Hp (Tegtmeyer
et al., 2009) is a second pathway upstream of cortactin asost & Microbe 9, 520–531, June 16, 2011 ª2011 Elsevier Inc. 527
Figure 7. Model for the Role of Cortactin Phosphorylation in Interaction with FAK during Hp Infection
(A) Schematic presentation of the domain structure of cortactin with the known ERK1/2, PAK1, and Src phosphorylation sites. Phosphorylation may cause
a switch in cortactin and makes the SH3 domain accessible for protein/protein interactions.
(B) Phosphorylation-dependent binding of FAK is shown.
(C) During the course of Hp infection two independent signaling pathways are activated leading to the (1) tyrosine dephosphorylation and (2) serine
phosphorylation of cortactin as indicated. Cortactin phosphorylated at S-405, but not S-113 or S-418, plays a central role for the interaction with FAK at PR3. The
interaction of cortactin with FAK induces the phosphorylation at Y-397 and other sites resulting in significantly increased kinase activity of FAK.
Cell Host & Microbe
Cortactin Targets FAK and Its Kinase Activityobserved inother cell systems (Campbell et al., 1999). Inmanycell
types, cortactin is present as 80/85 kDa bands, but their phos-
phorylation status remained unclear. Interestingly, infection with
Hp specifically generated these two cortactin populations in
AGS cells with p80 being phosphorylated at S-113 and S-418,
and p85 phosphorylated at S-113 and S-405. This suggests that
phosphorylation of S-405 may play a crucial role for generating
p85, but other modifications were also considered (Kelley et al.,
2010). Interestingly, cortactin p85 is predominantly expressed in
colorectal cancer tissue samples but not in control cells (Zhang528 Cell Host & Microbe 9, 520–531, June 16, 2011 ª2011 Elsevier Inet al., 2006). This let us propose that phosphorylation of cortactin
at S-405 and p85 induction may be important for changing
cortactin’s conformation and downstream signaling by Hp.
Interaction of Serine-Phosphorylated Cortactin
with FAK
Structural analysis of nonphosphorylated cortactin showed that
it adopts a globular structure, which is mainly maintained by
interactions of the SH3 domain either with the helical or F-actin
binding domains (Cowieson et al., 2008). Thus, the SH3 domainc.
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raises the possibility that phosphorylation acts as a molecular
switch that induces conformational changes in the cortactin
molecule that liberate the SH3 domain (Figure 7A). Having estab-
lished that Hp induces profound serine phosphorylation of cor-
tactin, we aimed to investigate downstream signaling. It was
tempting to speculate that serine-phosphorylated cortactin
would interact with already published interaction partners. To
our surprise, none of the known interaction partners, including
N-WASP, MLCK, Crk, actin, and others, were found in IPs with
cortactin after infection. Instead, we discovered FAK as a binding
factor of cortactin based on immunofluerescence and IP exper-
iments during transfection and infection and using in vitro GST
pulldown studies. Using phosphorylation-deficient or phosphor-
ylation-mimetic cortactin constructs we could then demonstrate
that phosphorylation of cortactin at S-405 and to lesser extent by
S-418 (but not both serine residues simultaneously) triggered the
interaction with FAK, while phosphorylation at Y-421, Y-466, and
Y-482 had suppressive effects (Figure 7B). These findings are
consistent with the positive and negative regulatory effects of
respective cortactin mutants in the Hp-induced phenotype. We
propose that the consequences over cortactin structure of
each serine-phophorylation site (S-405 or S-418) might be
different. This is further supported by the observation that
N-WASP can bind to cortactin S405/418D (Martinez-Quiles
et al., 2004) but not in Hp infection (this study). However, we
focused here on FAK and identified a PxxP motif, named PR3,
which is involved in this binding. Thus, cortactin and FAK interact
directly by a classical SH3-PxxP interaction.
Distinct Roles of Cortactin Molecules Phosphorylated
at S-113, S-405, or S-418
Our data also revealed that each of the investigated serine phos-
phorylation sites in cortactin have distinct functions for pheno-
typic outcome (Figure 7C). First, expression of S405A and
S418A mutants had significant inhibitory effect on the scattering
phenotype, while expression of single phosphomimetic S405D
and S418D mutants (but not the double S405/418D mutant)
enhanced it. Remarkably, we found that phosphorylation of
S-405 is only found in p85 and phosphorylation of S-418 is
only found in p80. Thus, both sites are never phosphorylated
at the same cortactin molecule. It appears that cortactin mainly
phosphorylated at S-405 facilitates binding to FAK and activa-
tion of its kinase activity at various phospho-sites, including
Y-397, Y-407, or Y-576, both in vitro and in vivo. Thus, this inter-
action influences focal adhesion turnover and cell attachment
important in cell motility and elongation. The outcome of infected
AGS cells in vitro is that scattering cells simply elongate because
the lagging ends cannot detach properly during migration due to
enhanced FAK activity at these sites. However, cortactin phos-
phorylated at S-418 binds FAK tomuch less extent as compared
to S-405 and did not stimulate FAK kinase activity, thus obvi-
ously having a different function. A recent study showed that
expression of cortactin S405/418 phosphorylation null con-
structs impaired carcinoma motility and adhesion and also in-
hibited lamellipodia persistence as monitored by live-cell
imaging (Kelley et al., 2010). Cortactin phosphorylated at
S-418 localized to sites of dynamic actin assembly in lamelipodia
of migrating cancer cells (Kelley et al., 2010). An intriguing possi-Cell Hbilty is that the latter cortactin form interacts with other mole-
cule(s) to regulate actin dynamics in lamellipodia persistence.
In the Hp model, this molecule seems not to be N-WASP, and
therefore it should be identified in future studies. Finally, infection
withHp induced the phosphorylation of S-113 in cortactin. Phos-
phorylation of S-113 by PAK is not required for the translocation
of cortactin to podosomes, lamellipodia or membrane in smooth
muscle cells (Webb et al., 2006). However, phosphorylation by
PAK significantly reduced binding of cortactin to F-actin (Webb
et al., 2006) which is in agreement with our IP experiments and
the finding that mutation of S113A had inhibitory effects on
phenotypical outcome.
Role of Cortactin in Infections with Other Pathogens
Several other bacterial pathogens have been also reported to
modify cortactin phosphorylation and/or localization during
infection. For example, invasion of gastric epithelial cells by
Shigella flexneri induces the tyrosine phosphorylation of cortac-
tin by a c-Src-dependent pathway andCrk was shown to directly
interact with tyrosine-phosphorylated cortactin to promote cor-
tactin-dependent actin polymerization required for Shigella
uptake (Bougne`res et al., 2004; Nhieu et al., 2005). Similarly,
invasion of host cells by Neisseria meningitidis and Staphylo-
coccus aureus stimulates cortactin tyrosine phosphorylation
(Hoffmann et al., 2001; Agerer et al., 2005). In addition, EPEC
and EHEC recruit cortactin to the bacterial adhesion site in actin
pedestals involving changes of its tyrosine phosphorylation
(Cantarelli et al., 2007; Nieto-Pelegrin and Martinez-Quiles,
2009). Consequently, tyrosine phosphorylation of cortactin
seems to play a role in bacterial invasion (Shigella, Neisseria,
and Staphylococcus) and attachment/pedestal formation of
extracellular bacteria (EPEC and EHEC). Cortactin also appears
to have a role in Listeria invasion, but the phosphorylation status
is not clear (Barroso et al., 2006; Veiga and Cossart, 2005). We
show that Hp specifically induces the tyrosine dephosphoryla-
tion and serine phosphorylation of cortactin. Similarly to Shigella
and Neisseria, the activity of Src in infected cells determines the
level of cortactin phosphorylation. In contrast to the latter path-
ogens, however, cortactin does not appear to be involved in
Hp invasion or attachment (Selbach and Backert, 2005). Since
injected CagA highjacks Par1 kinase to disrupt cell polarity (Saa-
dat et al., 2007), Hp has an important impact on disturbing the
integrity of the infected gastric epithelium, probably to loosen
cell-to-cell junctions locally in order to gain access to certain
nutrients which are absent in the gastric lumen. We propose
that Hp therefore targets cortactin to enhance FAK activity as
a straightforward mechanism to protect the gastric epithelium
from excessive cell lifting from the substratum to ensure the life-
long infection process at the epithelial surface. Since this
signaling is associated with AGS cell scattering and elongation
in vitro, this could also have important consequences for certain
disease-associated events in vivo. Therefore, it will be interesting
to determine in future studies whether serine phosphorylation of
cortactin also plays a role in infections with other pathogens, and
to characterize the associated signaling pathways.
Conclusions
Cortactin is a central regulator of the host actin cytoskeleton.
Moreover, it was called an Achilles’ heel of the actin cytoskeletonost & Microbe 9, 520–531, June 16, 2011 ª2011 Elsevier Inc. 529
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Cortactin Targets FAK and Its Kinase Activitybecause many pathogens highjack signals that converge on this
scaffolding protein. Here, we gave insights on the role and regu-
lation of cortactin phosphorylation events and downstream
signaling, which contributes significantly to our better under-
standing of the molecular action of this protein. Using Hp as
a model system, we characterized a molecular switch between
tyrosine and serine phosphorylation in cortactin. We discovered
an interaction partner of cortactin which was identified as FAK
and we present a pathway leading to FAK activation (Figure 7C).
In this way Hp targets cortactin by two independent processes:
(1) tyrosine dephosphorylation (CagA -dependent) and then (2)
serine phosphorylation (CagA independent). Both events are
essential for cortactin-FAK interaction, and the stimulation of
FAK activity is involved in deregulating normal cell adhesion
processes. In summary, the characteristic changes in mor-
phology of infected AGS cells resemble the process of onco-
genic transformation and involve Src inactivation as well as
FAK activation. Since CagA-positive Hp are associated with
the onset of gastric cancer (Polk and Peek, 2010), it is tempting
to speculate that CagA also contributes to oncogenic transfor-
mation of infected cells by interfering with c-Src, ERK1/2, and
PAK1 signaling to cortactin. Interestingly, the gene encoding
cortactin is amplified in some human cancers and cortactin is
suspected to play a major role in tumor invasion (Schuuring
et al., 1993). Thus, it will be interesting to find out in future studies
how Hp-mediated disruption of signaling to cortactin could
contribute to the onset of gastric cancer in vivo.
EXPERIMENTAL PROCEDURES
Cell Culture and Bacteria
The human gastric adenocarcinoma cell line AGS was obtained from ATCC
(CRL 1739). Mouse knockout fibroblast cells for FAK / (Sieg et al., 2000)
and cortactin/ (Lai et al., 2009) were described previously. The Hp WT
strains P1, P12, and NCTC11637 and their isogenic DcagA mutants were
grown on agar plates under microaerophilic conditions. For infection, bacteria
were added at a multiplicity of infection of 100. The number of elongated AGS
cells in each experiment was quantified in 10 different 0.25 mm2 fields (Tegt-
meyer et al., 2009). All experiments were done in triplicate.
Cell Fractionation, Inhibitors, IPs, Western Blotting, and Antibodies
Biochemical separation of infected AGS cells into cytosolic and membrane
fractions was previously described (Kwok et al., 2007). The FAK inhibitor
PF-573228 was added 30 min prior to infection according to the manufacturer
(Tocris Bioscience). Treated/infected cells were harvested in ice-cold PBS
containing 1 mmol/liter Na3VO4 (Sigma-Aldrich). IPs and western blotting
were done as previously described (Tegtmeyer et al., 2009). Band intensities
were quantitated with the Lumi-Imager F1 (Roche). Antibodies used in this
work are described in the Supplemental Experimental Procedures.
In Vitro Phosphorylation and GST Pulldown
Full-length mouse cortactin was cloned as GST-fusion protein and purified as
described (Martinez-Quiles et al., 2004). Three micrograms GST-cortactin
were incubated with 0.5 mg ERK2 kinase (Cell Sciences) in 13 kinase buffer
(NEB) containing 0.4mMATP for 30min at 30C. Phosphorylated GST-cortac-
tin was purified with the GST Pull-Down Kit according to the instructions of the
supplier (Pierce). Recombinant full-length human FAK (0.3 mg, Biosource) was
added to purified cortactin followed by incubation for 1 hr at 30C followed by
GST pulldown.
Cell Attachment Assays
AGS cell attachment and spreading assays were performed according to
procedures described previously (Tegtmeyer et al., 2010). In brief, Petri dishes530 Cell Host & Microbe 9, 520–531, June 16, 2011 ª2011 Elsevier Inwere coated with 200 ml of 50 mg/ml human fibronectin (Sigma) or polylysine
(0.01% solution, Sigma) at 4C overnight. Nonspecific binding sites were
blocked by incubation with 5% BSA. Confluent AGS cells were trypsinised
and treated with soybean trypsin inhibitor according to the instructions of
the supplier (Sigma). After washingwith PBS, 43 106 cells in RPMIwere added
to the precoated petri dishes (or left untreated in the test tube) and incubated
for 3 hr where more than 80% of the cells adhered properly.
Immunofluorescence Microscopy
For immunofluorescence staining, cells were fixed with 3.4% PFA, permeabi-
lized with 0.5% Triton X-100 in PBS, and blocked with 1% BSA. Proteins were
stained with a-FAK and a-cortactin 4F11 antibodies. As secondary antibodies,
TRITC-conjugated a-mouse or FITC-conjugated a-rabbit immunoglobulins
were used (Sigma). F-actin was detected with Alexa Fluor 350-conjugated
phalloidin (Invitrogen). Samples were analyzed with a Leica DMRE7 fluores-
cence microscope (Kwok et al., 2007).
Plasmids, Mutagenesis, and Transfection of DNA and siRNA
Plasmids, DNA mutagenesis, siRNAs and transfection experiments used in
this work are described in the Supplemental Experimental Procedures.
Statistical Analysis
All data were evaluated via Student’s t test with SigmaStat statistical
software (version 2.0). Statistical significance was defined by p % 0.01 (*)
and p% 0.001 (**).
SUPPLEMENTAL INFORMATION
Supplemental Information includes Supplemental Experimental Procedures
and five figures and can be found with this article online at doi:10.1016/j.
chom.2011.05.007.
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